<SEC-DOCUMENT>0001213900-24-046796-index.html : 20240528 <SEC-HEADER>0001213900-24-046796.hdr.sgml : 20240528 <ACCEPTANCE-DATETIME>20240528071429 ACCESSION NUMBER: 0001213900-24-046796 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20240528 FILED AS OF DATE: 20240528 DATE AS OF CHANGE: 20240528 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NeuroSense Therapeutics Ltd. CENTRAL INDEX KEY: 0001875091 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41084 FILM NUMBER: 24986259 BUSINESS ADDRESS: STREET 1: 11 HAMENOFIM ST. STREET 2: BUILDING B CITY: HERZLIYA STATE: L3 ZIP: 4672562 BUSINESS PHONE: 972-9-9531142 MAIL ADDRESS: STREET 1: 11 HAMENOFIM ST. STREET 2: BUILDING B CITY: HERZLIYA STATE: L3 ZIP: 4672562 </SEC-HEADER> <DOCUMENT> <TYPE>6-K <SEQUENCE>1 <FILENAME>ea0206851-6k_neurose.htm <DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER <TEXT> Document 1 - file: ea0206851-6k_neurose.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>ea020685101ex99-1_neurose.htm <DESCRIPTION>NOTICE AND PROXY STATEMENT FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS OF THE REGISTRANT SCHEDULED FOR JUNE 27, 2024 <TEXT> Document 2 - file: ea020685101ex99-1_neurose.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>3 <FILENAME>ea020685101ex99-2_neurose.htm <DESCRIPTION>PROXY CARD <TEXT> Document 3 - file: ea020685101ex99-2_neurose.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>ex99-1_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: ex99-1_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>ex99-2_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: ex99-2_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>ex99-2_002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: ex99-2_002.jpg
</DOCUMENT> </SEC-DOCUMENT>